# Study of SG301 for Renal AMR After Transplantation

> clinical trial · VERIFIED · 2026-08-17

Status: NOT_YET_RECRUITING · Sponsor: Hangzhou Sumgen Biotech Co., Ltd. · Condition: Antibody Mediated Rejection

- Company: Hangzhou Sumgen Biotech Co., Ltd.
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT07764627

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.